CAR19BCMA CAR-T cell
/ Chinese PLA General Hospital
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
July 25, 2025
CAR19BCMA CAR-T Cells for the Treatment of R/R Plasma Cell Neoplasms
(clinicaltrials.gov)
- P1 | N=20 | Not yet recruiting | Sponsor: Chinese PLA General Hospital
New P1 trial • Hematological Malignancies • Multiple Myeloma • Oncology • Plasmacytoma
1 to 1
Of
1
Go to page
1